ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2019

Identification of subgroups of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone plus prednisone at low- vs. high-risk of radiographic progression: An analysis of COU-AA-302.

Lisa J Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.